March 6, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S.
March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from a late-breaking presentation showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
Picture archiving and communication systems (PACS) play a crucial role in modern radiology by providing a digital platform for the storage, retrieval, distribution and presentation of medical images. A PACS acts as a computer network for digitized radiological images and reports.
If you enjoy this content, please share it with a colleague
Industry trade shows and conferences seem to be making their comeback. The Healthcare Information and Management Systems Society (HIMSS) Global Conference and Exhibition was particularly poised to deliver the best of the best when it comes to digital transformation in both the delivery of healthcare and a quality experience for those in this demanding, rapidly evolving industry.
If you enjoy this content, please share it with a colleague
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision.
Other benefits of cardiac PET include consistent, high-quality images, low radiation exposure and short acquisition protocols. It also provides quantification of myocardial blood flow and strong prognostic power.*
If you enjoy this content, please share it with a colleague